Tag: $Apogee Therapeutics Inc

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push

 AbbVie said on Monday it would buy biotech Apogee Therapeutics for $10.9 billion, ​in its largest buyout in more than five years to strengthen its next-gen ‌immunology pipeline.